Celtic Resources Holdings PLC
01 October 2007
1 October 2007
Celtic Resources Holdings Plc
("Celtic" or the "Company")
Celtic enters into agreement to purchase concentrates
Celtic is pleased to announce that it has entered into an agreement with a
subsidiary of European Goldfields Limited, Hellas Gold S.A. ("Hellas Gold"), for
the purchase of 50,000 tonnes of concentrates containing approximately 30,000 oz
of gold.
As announced on 22 September 2006, the Company acquired 9,000 tonnes of
concentrate containing approximately 6,000 oz of gold, to be processed on a
trial basis, by Celtic at its Suzdal BIOX(R) plant in Kazakhstan. The Company
also announced that, if the initial shipments proved successful, it intended to
purchase up to an additional 120,000 tonnes of concentrates from Hellas Gold.
The Company has been very satisfied by the results of the trial and is therefore
announcing an agreement to purchase a further 50,000 tonnes of concentrates,
with shipments expected to be completed by the end of September 2009.
The Company operates the only BIOX(R) plant in the FSU for the treatment of
refractory sulphide ores and in addition to treating ore produced at its Suzdal
mine, it will be utilising available BIOX(R) capacity to produce more gold.
Suzdal has produced over 28,599 oz of gold in the last three months, which
includes 11,780 oz produced in September, at an average sale price of US$718 per
oz.
Kevin Foo, Managing Director of Celtic, said, "We have been delighted with the
results of our initial trial to process third party concentrates at our Suzdal
BIOX(R) plant. This agreement is a significant step forward in our strategy to
capitalise on our technology advantages at Suzdal and we are also looking at
other third party concentrate opportunities within Kazakhstan and Russia, as
many refractory gold ores remain unexploited."
Contact information:
Kevin Foo / Jonathan Scott-Barrett
Celtic Resources Holdings Plc
Tel: + 44 (0)20 7921 8800
Investors@celtic resources.com
Leesa Peters / Jane Stacey
Conduit PR
Tel: +44 (0)20 7429 6606 / (0)792 292 3306
leesa@conduitpr.com
Anthony Cardew
Cardew Group
Tel: +44 (0)20 7930 0777
anthony.cardew@cardewgroup.com
Strand Partners Limited
Simon Raggett
Stuart Faulkner
Tel: +44 (0)20 7409 3494
About the Suzdal BIOX(R) plant:
Celtic has successfully developed the first BIOX(R) plant for treatment of
refractory sulphide ores in the FSU at its Suzdal mine in Kazakhstan. The plant
uses a sulphide oxidation process for recovering gold from refractory ores or
concentrates. The process utilises a mixed population of naturally occurring
bacteria, that are present in all sulphide ores, to break down the sulphide
mineral matrix, thereby liberating the occluded gold for subsequent cyanidation.
The BIOX(R) process acts as an alternative to conventional processes of roasting
and pressure oxidation and offers advantages of reduced capital cost, simplicity
of operations, robustness and very low environmental impact.
Any person who is the holder of 1 per cent. or more of any class of shares in
Celtic may be required to make disclosures pursuant to Rule 8.3 of the Irish
Takeover Panel Act, 1997, Takeover Rules 2001 to 2006.
The Directors of Celtic accept responsibility for the information contained in
this announcement and to the best of their knowledge and belief (having taken
all reasonable care to ensure that such is the case), the information contained
in this announcement is in accordance with the facts and, where appropriate,
does not omit anything likely to affect the import of such information.
This information is provided by RNS
The company news service from the London Stock Exchange
D
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.